Cargando…

Health care delivery system contributions to management of newly diagnosed prostate cancer

BACKGROUND: Despite clinical guidelines advocating for use of conservative management in specific clinical scenarios for men with prostate cancer, there continues to be tremendous variation in its uptake. This variation may be amplified among men with competing health risks, for whom treatment decis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krampe, Noah, Kaufman, Samuel R., Oerline, Mary K., Hill, Dawson, Caram, Megan E. V., Shahinian, Vahakn B., Hollenbeck, Brent K., Maganty, Avinash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501260/ https://www.ncbi.nlm.nih.gov/pubmed/37475511 http://dx.doi.org/10.1002/cam4.6349

Ejemplares similares

In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer
por: Hill, Dawson, et al.
Publicado: (2023)

Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer
por: Lai, Lillian Y, et al.
Publicado: (2022)

Reimbursement and use of intensity-modulated radiation therapy for prostate cancer
por: Shahinian, Vahakn B., et al.
Publicado: (2017)

Differential adoption of castration‐resistant prostate cancer treatment across facilities in a national healthcare system
por: Caram, Megan E. V., et al.
Publicado: (2023)

Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer
por: Skolarus, Ted A., et al.
Publicado: (2021)

De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)
por: Skolarus, Ted A., et al.
Publicado: (2018)

Correction: Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer
por: Skolarus, Ted A., et al.
Publicado: (2023)

Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer
por: Shahinian, Vahakn B, et al.
Publicado: (2015)

Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer
por: Kuo, Yong-fang, et al.
Publicado: (2008)

International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries
por: Liede, Alexander, et al.
Publicado: (2016)

Association between PSA values and surveillance quality after prostate cancer surgery
por: Chapman, Christina Hunter, et al.
Publicado: (2019)

The clinical epidemiology of fatigue in newly diagnosed heart failure
por: Williams, Brent A.
Publicado: (2017)

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

The putative mechanisms underlying testosterone and cardiovascular risk
por: Maganty, Avinash, et al.
Publicado: (2014)

Considering renal risk while managing cancer
por: Shahinian, Vahakn B, et al.
Publicado: (2017)

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer
por: Reyes, D. K., et al.
Publicado: (2020)

Treatment patterns and survival of low and intermediate‐risk prostate cancer in end‐stage kidney disease: A retrospective population cohort study
por: Sarabu, Nagaraju, et al.
Publicado: (2023)

Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer
por: Caram, Megan E. V., et al.
Publicado: (2019)

Dramatic mixed response of lymphangitic pulmonary metastases in newly diagnosed prostate cancer
por: Gorshein, Elan, et al.
Publicado: (2017)

The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
por: Parker, Daniel C., et al.
Publicado: (2020)

Contributions of T Lymphocyte Abnormalities to Therapeutic Outcomes in Newly Diagnosed Patients with Immune Thrombocytopenia
por: Zhao, Zhenhua, et al.
Publicado: (2015)

Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2021)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Daratumumab in untreated newly diagnosed multiple myeloma
por: Abdallah, Nadine, et al.
Publicado: (2019)

Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer
por: Urbanek, Cydney, et al.
Publicado: (2011)

Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups
por: Sevcenco, Sabina, et al.
Publicado: (2019)

Health-related quality of life in patients newly diagnosed with prostate cancer: CAPLIFE study
por: Lozano-Lorca, Macarena, et al.
Publicado: (2022)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

Temporal and geographic variation in the systemic treatment of advanced prostate cancer
por: Caram, Megan E. V., et al.
Publicado: (2018)

Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer
por: Bosco, Jaclyn LF, et al.
Publicado: (2012)

A Pilot Trial of Pembrolizumab plus Prostatic Cryotherapy for Men with Newly Diagnosed Oligometastatic Hormone-Sensitive Prostate Cancer
por: Ross, Ashley E., et al.
Publicado: (2019)

Evaluating the online delivery of an autistic-led programme to support newly diagnosed or identified autistic adults
por: Crane, Laura, et al.
Publicado: (2023)

When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study
por: Lin, Yiwei, et al.
Publicado: (2017)

Alteration of cardiac autonomic function in patients with newly diagnosed epilepsy
por: Goit, Rajesh K., et al.
Publicado: (2016)

Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report
por: Lemoine, Chantal, et al.
Publicado: (2022)

Hemorrhagic Pericardial Effusion as the Presenting Symptom of Newly Diagnosed Rheumatoid Arthritis
por: Basile, Eric J, et al.
Publicado: (2022)

Prostate cryoablation combined with androgen deprivation therapy for newly diagnosed metastatic prostate cancer: a propensity score-based study
por: wang, Ning, et al.
Publicado: (2021)

Newly Diagnosed Acute Promyelocytic Leukemia
por: Avvisati, Giuseppe
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_41j8peks219bb2qvjai987gqa6